Jeremy Levin

Jeremy Levin

Company: Ovid Therapeutics

Job title: CEO & Chairman

Seminars:

Chair’s Closing Remarks 6:15 pm

Read more

day: Day Two

Symptomatic vs Genetic Disease Modifying Treatments 9:10 am

Most industry portfolios reflect either a strategic balance between, or unitary commitment to either small molecule or genetic modalities for engaging targets involved in the biological processes implicated in rare diseases of the central nervous system. This panel will explore key strategic, technical, and scientific considerations shaping these decisions. • How can we assess benefit/risk…Read more

day: Day One

Chair’s Opening Remarks 8:30 am

Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.